Quantcast

Latest Cancer Research Stories

2014-04-02 16:23:15

DUBLIN, Apr. 02, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/gd4n67/global_and ) has announced the addition of the "Global and Chinese Feed Chlortetracycline Industry Report 2014" report to their offering. (Logo:http://photos.prnewswire.com/prnh/20130307/600769) The Global and Chinese Feed Chlortetracycline Industry Report 2014 is a professional and in-depth study on the current state of the global feed chlortetracycline industry with a focus on...

2014-04-02 08:32:57

--First-in-Class CLIA Assay for Detection of Tumor-Specific Gene Amplifications Using Circulating Cell-Free DNA-- BALTIMORE, April 2, 2014 /PRNewswire/ -- Personal Genome Diagnostics Inc. (PGDx), a provider of advanced cancer genome analyses, today announced the launch of its METDetect(TM) Assay for the detection of MET gene amplifications in the circulation of cancer patients. Amplifications and other structural changes of the MET cancer gene have been associated with resistance to...

2014-04-01 23:32:32

On Sunday, April 6, performing art students in Interlochen, MI will present a collection of music, acting, poetry and dance to benefit the Damon Runyon Cancer Research Foundation. Interlochen, MI (PRWEB) April 01, 2014 Organizers of “I Perform For,” a free cancer benefit concert, announced today they will be presenting their third annual concert this Sunday, April 6, 2014 at 7:30 pm EST. Performing arts enthusiasts can view the invite-only performance online via a live broadcast...

2014-04-01 08:28:44

SAN DIEGO, April 1, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, today announced that clinical data from a study using the company's cancer monitoring platform for the detection and longitudinal monitoring of BRAF V600E mutations will be the subject of a late-breaking poster presentation at the American Association for Cancer Research Annual Meeting in San Diego, California....

2014-03-31 08:30:41

Morgan Stanley's Head of Global Biotech Investment Banking Joins Leading Cancer Immunotherapy Startup SEATTLE, March 31, 2014 /PRNewswire/ -- Juno Therapeutics, a biotechnology company focused on bringing forward novel immunotherapies for cancer, announced today that Steve Harr, M.D., will join the company as its Chief Financial Officer and Head of Corporate Development. http://photos.prnewswire.com/prnvar/20140113/DC45426LOGO Harr currently serves as Managing Director and Head of...

2014-03-27 12:30:31

Portion of Proceeds from Connexion 2014 Earmarked to Provide Financial and Emotional Relief for Families and Patients Battling Cancer FOXBORO, Mass., March 27, 2014 /PRNewswire/ -- Axeda Corporation, the leading cloud-based service and software for connecting, building and managing Internet of Things (IoT) solutions, today announced its support of the Joe Andruzzi Foundation (JAF), a Massachusetts-based nonprofit 5019(c)(3) organization dedicated to alleviating cancer's financial and...

2014-03-26 16:11:46

A breast cancer therapy that blocks estrogen synthesis to activate cancer-killing genes sometimes loses its effectiveness because the cancer takes over epigenetic mechanisms, including permanent DNA modifications in the patient's tumor, once again allowing tumor growth, according to an international team headed by the University of Pittsburgh Cancer Institute (UPCI). The finding warrants research into adding drugs that could prevent the cancer from hijacking patients' repressive gene...

2014-03-26 12:28:50

Enabled Reduced Analysis Time Per Case, Improved Ability to Track & Query Identified Variants BOSTON and LEUVEN, Belgium, March 26, 2014 /PRNewswire/ -- Cartagenia, the world leader in software-based workflow support for genetic variant assessment, lab reporting, and integration of diagnostic knowledge-bases, today announced that the Human Genetics Laboratory, part of the Munroe-Meyer Institute for Genetics and Rehabilitation (MMI) at the University of Nebraska Medical Center (UNMC),...

2014-03-25 23:32:12

The globally standardized certification methodology is now accepted across healthcare organizations, clinical trial sponsors, CROs and regulatory agencies. Austin, TX (PRWEB) March 25, 2014 More than 500,000 healthcare and clinical research professionals in 164 countries representing every continent have been trained and certified on the NIH Stroke Scale (NIHSS) and can now share their standardized certifications electronically across employees, sponsors and clinical trials via HCP’s...

2014-03-24 12:29:44

WASHINGTON, March 24, 2014 /PRNewswire-USNewswire/ -- The American Society of Hematology (ASH), the world's largest professional society concerned with the causes and treatment of blood disorders, today announced the names of 15 research investigators who will receive critical interim support from the Society for hematology research proposals that, despite earning high scores, could not be funded by the National Institutes of Health (NIH) amid severe funding reductions. The support...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.